BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Streiff MB, Bockenstedt PL, Cataland SR, Chesney C, Eby C, Fanikos J, Fogarty PF, Gao S, Garcia-Aguilar J, Goldhaber SZ, Hassoun H, Hendrie P, Holmstrom B, Jones KA, Kuderer N, Lee JT, Millenson MM, Neff AT, Ortel TL, Smith JL, Yee GC, Zakarija A. Venous thromboembolic disease. J Natl Compr Canc Netw 2011;9:714-77. [PMID: 21715723 DOI: 10.6004/jnccn.2011.0062] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 4.9] [Reference Citation Analysis]
Number Citing Articles
1 Che D, Cao J, Shang L, Man Y, Yu Y. The efficacy and safety of low-molecular-weight heparin use for cancer treatment: A meta-analysis. European Journal of Internal Medicine 2013;24:433-9. [DOI: 10.1016/j.ejim.2013.01.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
2 Barsam SJ, Patel R, Arya R. Anticoagulation for prevention and treatment of cancer-related venous thromboembolism. Br J Haematol 2013;161:764-77. [DOI: 10.1111/bjh.12314] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
3 Rajasekhar A. Inferior vena cava filters: current best practices. J Thromb Thrombolysis 2015;39:315-27. [PMID: 25680894 DOI: 10.1007/s11239-015-1187-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
4 Walker AJ, Baldwin DR, Card TR, Powell HA, Hubbard RB, Grainge MJ. Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data. Br J Cancer 2016;115:115-21. [PMID: 27253177 DOI: 10.1038/bjc.2016.143] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
5 Smart P, Burbury K, Lingaratnam S, Lynch AC, Mackay J, Heriot A. Thromboprophylaxis among Australasian colorectal surgeons: Thromboprophylaxis in colon cancer. ANZ J Surg 2013;83:646-50. [DOI: 10.1111/j.1445-2197.2012.06245.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zhu HJ, Hess S, Rubello D, Goris ML, Alavi A. The strong but nonspecific relationship between 18F-FDG uptake in the lower-extremity veins and venous thromboembolism. Nucl Med Commun 2016;37:322-8. [PMID: 26671850 DOI: 10.1097/MNM.0000000000000442] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Walenga JM, Lyman GH. Evolution of heparin anticoagulants to ultra-low-molecular-weight heparins: a review of pharmacologic and clinical differences and applications in patients with cancer. Crit Rev Oncol Hematol 2013;88:1-18. [PMID: 23849978 DOI: 10.1016/j.critrevonc.2013.06.007] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
8 Smart PJ, Burbury KL, Lynch AC, Mackay JR, Heriot AG. Thromboembolism During Neoadjuvant Therapy for Gastrointestinal Cancer. American Journal of Clinical Oncology 2014;37:627-34. [DOI: 10.1097/coc.0b013e318280d78a] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Ko RH, Thornburg CD. Venous Thromboembolism in Children with Cancer and Blood Disorders. Front Pediatr 2017;5:12. [PMID: 28220143 DOI: 10.3389/fped.2017.00012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
10 Maxwell WD, Bennett CL. Thromboprophylaxis guidelines in cancer with a primary focus on ambulatory patients receiving chemotherapy: a review from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost 2012;38:759-67. [PMID: 23111863 DOI: 10.1055/s-0032-1328893] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
11 Cai Y, Yang W, Yin R, Zhou L, Li Z, Wu M, Zhao J. An anticoagulant fucan sulfate with hexasaccharide repeating units from the sea cucumber Holothuria albiventer. Carbohydrate Research 2018;464:12-8. [DOI: 10.1016/j.carres.2018.05.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
12 Fotiou D, Gerotziafas G, Kastritis E, Dimopoulos MA, Terpos E. A review of the venous thrombotic issues associated with multiple myeloma. Expert Review of Hematology 2016;9:695-706. [DOI: 10.1080/17474086.2016.1194750] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
13 Ordookhani A, Motazedi A, Burman KD. Thrombosis in Thyroid Cancer. Int J Endocrinol Metab 2018;16:e57897. [PMID: 29696039 DOI: 10.5812/ijem.57897] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
14 Temraz S, Tamim H, Mailhac A, Taher A. Could sodium imbalances predispose to postoperative venous thromboembolism? An analysis of the NSQIP database. Thromb J 2018;16:11. [PMID: 29988709 DOI: 10.1186/s12959-018-0165-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
15 Cohen AT, Gurwith MM, Dobromirski M. Thromboprophylaxis in non-surgical cancer patients. Thromb Res. 2012;129 Suppl 1:S137-S145. [PMID: 22682125 DOI: 10.1016/s0049-3848(12)70034-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
16 Piazza G. Venous thromboembolism and cancer. Circulation 2013;128:2614-8. [PMID: 24344060 DOI: 10.1161/CIRCULATIONAHA.113.002702] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
17 Rank CU, Lynggaard LS, Als-Nielsen B, Stock W, Toft N, Nielsen OJ, Frandsen TL, Tuckuviene R, Schmiegelow K. Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia. Cochrane Database Syst Rev 2020;10:CD013399. [PMID: 33038027 DOI: 10.1002/14651858.CD013399.pub2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Falanga A, Marchetti M, Vignoli A. Coagulation and cancer: biological and clinical aspects. J Thromb Haemost. 2013;11:223-233. [PMID: 23279708 DOI: 10.1111/jth.12075] [Cited by in Crossref: 198] [Cited by in F6Publishing: 192] [Article Influence: 24.8] [Reference Citation Analysis]
19 Piazza G, Rao AF, Nguyen TN, Seger AC, Hohlfelder B, Fanikos J, Goldhaber SZ. Venous Thromboembolism in Hospitalized Patients With Active Cancer. Clin Appl Thromb Hemost 2013;19:469-75. [DOI: 10.1177/1076029613481844] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
20 Jeon HK, Kim DU, Baek DH, Ha DW, Lee BE, Ryu DY, Cheong JH, Kim GH, Song GA, Jang AL. Venous thromboembolism in patients with cholangiocarcinoma: focus on risk factors and impact on survival. Eur J Gastroenterol Hepatol 2012;24:444-9. [PMID: 22410715 DOI: 10.1097/MEG.0b013e328350f93c] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
21 Frere C, Benzidia I, Marjanovic Z, Farge D. Recent Advances in the Management of Cancer-Associated Thrombosis: New Hopes but New Challenges. Cancers (Basel). 2019;11. [PMID: 30634638 DOI: 10.3390/cancers11010071] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
22 Fanikos J, Rao A, Seger AC, Piazza G, Catapane E, Chen X, Goldhaber SZ. Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital discharge. Am J Med 2011;124:1143-50. [PMID: 22114828 DOI: 10.1016/j.amjmed.2011.07.031] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
23 Haruta S, Kawaguchi R, Hirai T, Kobayashi H. Sequential screening to predict symptomatic pulmonary thromboembolism after gynecologic surgery in Nara, Japan. International Journal of Gynecology & Obstetrics 2016;132:42-5. [DOI: 10.1016/j.ijgo.2015.06.048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
24 Seki JT, Vather T, Atenafu EG, Kukreti V, Krzyzanowska MK. Bridging efforts to longitudinally improve and evaluate VEnous thromboembolism prophylaxis uptake in hospitalized cancer patients through Interprofessional Teamwork (BELIEVE IT): a study by Princess Margaret Cancer Centre. Thromb Res 2014;133:34-41. [PMID: 24210735 DOI: 10.1016/j.thromres.2013.10.025] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
25 Horsted F, West J, Grainge MJ. Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis. PLoS Med. 2012;9:e1001275. [PMID: 22859911 DOI: 10.1371/journal.pmed.1001275] [Cited by in Crossref: 243] [Cited by in F6Publishing: 221] [Article Influence: 27.0] [Reference Citation Analysis]
26 Lyman GH, Khorana AA, Kuderer N, Prestrud AA, Falanga A. Reply to T.H. Oo. J Clin Oncol 2013;31:4381-2. [PMID: 24190116 DOI: 10.1200/JCO.2013.52.6244] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Wu M, Xu L, Zhao L, Xiao C, Gao N, Luo L, Yang L, Li Z, Chen L, Zhao J. Structural analysis and anticoagulant activities of the novel sulfated fucan possessing a regular well-defined repeating unit from sea cucumber. Mar Drugs 2015;13:2063-84. [PMID: 25871288 DOI: 10.3390/md13042063] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]
28 Luo L, Wu M, Xu L, Lian W, Xiang J, Lu F, Gao N, Xiao C, Wang S, Zhao J. Comparison of physicochemical characteristics and anticoagulant activities of polysaccharides from three sea cucumbers. Mar Drugs 2013;11:399-417. [PMID: 23385300 DOI: 10.3390/md11020399] [Cited by in Crossref: 103] [Cited by in F6Publishing: 91] [Article Influence: 12.9] [Reference Citation Analysis]
29 Utke Rank C, Lynggaard LS, Toft N, Nielsen OJ, Stock W, Als-nielsen B, Frandsen TL, Tuckuviene R, Schmiegelow K; Cochrane Haematological Malignancies Group. Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd013399] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Walker AJ, Card TR, West J, Crooks C, Grainge MJ. Incidence of venous thromboembolism in patients with cancer - a cohort study using linked United Kingdom databases. Eur J Cancer. 2013;49:1404-1413. [PMID: 23146958 DOI: 10.1016/j.ejca.2012.10.021] [Cited by in Crossref: 216] [Cited by in F6Publishing: 204] [Article Influence: 24.0] [Reference Citation Analysis]
31 Sandset PM. CXCL4-platelet factor 4, heparin-induced thrombocytopenia and cancer. Thromb Res 2012;129 Suppl 1:S97-100. [PMID: 22682144 DOI: 10.1016/S0049-3848(12)70026-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
32 Rajasekhar A, Streiff MB. Vena cava filters for management of venous thromboembolism: A clinical review. Blood Reviews 2013;27:225-41. [DOI: 10.1016/j.blre.2013.07.001] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 4.6] [Reference Citation Analysis]
33 Ye S, Zhang W, Yang J, Cao D, Huang H, Wu M, Lang J, Shen K. Pattern of Venous Thromboembolism Occurrence in Gynecologic Malignancy: Incidence, Timing, and Distribution a 10-Year Retrospective Single-institutional Study. Medicine (Baltimore) 2015;94:e2316. [PMID: 26683971 DOI: 10.1097/MD.0000000000002316] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 2.6] [Reference Citation Analysis]
34 Lyman GH, Eckert L, Wang Y, Wang H, Cohen A. Venous thromboembolism risk in patients with cancer receiving chemotherapy: a real-world analysis. Oncologist 2013;18:1321-9. [PMID: 24212499 DOI: 10.1634/theoncologist.2013-0226] [Cited by in Crossref: 109] [Cited by in F6Publishing: 88] [Article Influence: 13.6] [Reference Citation Analysis]
35 Walker AJ, Grainge MJ, Card TR, West J, Ranta S, Ludvigsson JF. Venous thromboembolism in children with cancer - a population-based cohort study. Thromb Res 2014;133:340-4. [PMID: 24388573 DOI: 10.1016/j.thromres.2013.12.021] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
36 Verso M, Agnelli G, Barni S, Gasparini G, LaBianca R. A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score. Intern Emerg Med. 2012;7:291-292. [PMID: 22547369 DOI: 10.1007/s11739-012-0784-y] [Cited by in Crossref: 178] [Cited by in F6Publishing: 163] [Article Influence: 19.8] [Reference Citation Analysis]
37 Blasi A, Molina V, Sanchez-cabús S, Balust J, Garcia-valdecasas JC, Taura P. Prediction of thromboembolic complications after liver resection for cholangiocarcinoma: is there a place for thromboelastometry? Blood Coagulation & Fibrinolysis 2018;29:61-6. [DOI: 10.1097/mbc.0000000000000672] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
38 Lau BD, Haut ER, Hobson DB, Kraus PS, Maritim C, Austin JM, Shermock KM, Maheshwari B, Allen PX, Almario A, Streiff MB. ICD-9 Code-Based Venous Thromboembolism Performance Targets Fail to Measure Up. Am J Med Qual 2016;31:448-53. [PMID: 25900895 DOI: 10.1177/1062860615583547] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
39 Shi S, Feng W, Hu S, Liang S, An N, Mao Y. Bioactive compounds of sea cucumbers and their therapeutic effects. Chin J Ocean Limnol 2016;34:549-58. [DOI: 10.1007/s00343-016-4334-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 3.2] [Reference Citation Analysis]
40 Wu M, Wen D, Gao N, Xiao C, Yang L, Xu L, Lian W, Peng W, Jiang J, Zhao J. Anticoagulant and antithrombotic evaluation of native fucosylated chondroitin sulfates and their derivatives as selective inhibitors of intrinsic factor Xase. European Journal of Medicinal Chemistry 2015;92:257-69. [DOI: 10.1016/j.ejmech.2014.12.054] [Cited by in Crossref: 84] [Cited by in F6Publishing: 76] [Article Influence: 14.0] [Reference Citation Analysis]